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Abstract To determine the relative importance of two 
known serotypes of human rotavirus, we developed an 
enzyme-linked immunosorbent assay to differentiate 
serotype-specific rotavirus antigen and antibody. 
Using this technic, we studied the epidemiology of the 
two serotypes in acute gastroenteritis. Seventy-seven 
per cent of 414 rotavirus isolates were Type 2, and the 
remainder were Type 1. The serotype distribution was 
similar in specimens from children in Washington D.C., 
and other parts of the world. Sero-
ROTAVIRUS is an important cause of gastroen-teritis of infants and children in many parts of the 
world.''2 Because the virus does not grow effi-ci,ently 
in tissue culture, conventional neutralization "methods 
cannot be used to examine its serotypic variations.''' 
Recently, two human rotavirus serotypes were 
distinguished by complement fixation,' immune 
electron microscopy' and immunofluorescence.6 The 
latter two methods are not practical for serotyping of 
large numbers of rotavirus-positive specimens where-
as complement fixation is not sensitive enough for use 
with low-titered preparations.
We recently described the technic of enzyme-linked 
immunosorbent assay for the detection of rotavirus 
antigen and antibody.'"" This assay is similar in design 
to radioimmunoassay but uses an enzyme instead of a 
radioactive isotope to quantitate binding of 
immunoglobulin. We modified the basic assay for de-
tection of rotavirus serotypes and used this new pro-
cedure to study the epidemiology of these viruses.
MATERIALS AND METHODS
Specimens
'Stool specimens containing rotavirus were collected from 278 in-il.
nts and children with gastroenteritis living in the Washington, D.C., 
area. From January, 1974, to October, 1976, only hospitalized 
patients were studied, whereas from November, 1976, to May, 1978, 
specimens from both inpatients and outpatients were available. This 
population has been described in detail.' In addition, 136 rotavirus-
containing specimens were available from children with and without 
gastroenteritis from other localities throughout the world. Included 
were rotavirus-positive stool specimens obtained
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epidemiologic studies revealed that most children liv-
ing in the Washington, D.C., area acquired antibody to 
both types by the age of two years. An analysis of 
children who were reinfected indicated that sequential 
infections usually involved different serotypes and 
that illness caused by one serotype did not provide re-
sistance to illness caused by the other serotype. 
These results suggest that, to be completely effective, 
a vaccine must provide resistance to both serotypes. (
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from a cohort of 19 children living in a rural village in Guatema-la 
who were sampled at regular intervals and during episodes of 
gastroenteritis. This population has also been described in detail." 
The specimens were tested as filtrates or suspensions at a concen-
tration ranging from 2 to 10 per cent. Suspensions containing visible 
solid material were clarified by centrifugation at 2000 rpm for 20 
minutes before testing. The specimens were stored at —70°C until 
tested. For the purposes of statistical analysis a season was defined 
as the period between October 1 of one year through September 30 
of the next year.
Acute-phase and convalescent-phase serum specimens were 
available from 18 children with gastroenteritis living in the United 
States. In addition, we examined paired serum samples from 14 
adult contacts of children with gastroenteritis and From 10 adult 
volunteers experimentally infected with Type 2 rotavirus. Also, 
serum and stool specimens were examined from three separate out-
breaks: (A) occurred in a play group in which infection spread to 
adult contacts; (B) occurred in a family that included an infant index 
case and her parents; and (C) occurred among sailors aboard a naval 
vessel. To determine the prevalence of antibody we examined a 
panel of 422 serum specimens. This panel consisted of acute-phase 
serum from children admitted to the hospital with predominantly 
respiratory illness, acute-phase serum from college students with 
predominantly respiratory illnesses and serum from normal adults, 
as previously described."
Colostrum was obtained from 43 women, 10 from Fairfax, 
Virginia, 21 from Costa Rica and 12 from a rural area in 
Guatemala. In addition, milk samples were obtained from 25 
mothers from rural Guatemala and 39 mothers from rural Bangla-
desh. The specimens of human milk were collected from two to 82 
weeks post partum.
Assay
The systems For enzyme-linked immunosorbent assay were modi-
fications of those used for the detection of antigen and antibody pre-
viously described.'-' The antigen assay is outlined as indicated below. 
First of all, goat anti-rotavirus antibody' is adhered to the well of a 
microtiter plate. This plate is stored at 4°C until use. Secondly, after 
washing, the test material is added. If rotavirus antigen is present it 
will adhere to the goat antiserum. Thirdly, after incubation for one 
hour at 37°C or overnight at 4°C, and washing, serotype-specific 
guinea-pig anti-rotavirus serum is added. The guinea-pig serum used 
was prepared by inoculation of complete rotavirus particles purified 
from human stool by sucrose sedimentation, as previously described.' 
We also found that guinea-pig serum raised against complete and 
incomplete particles of a serotype could be made serotype specific 
for antigen detection by absorption with preparations of tissue-
culture-grown calf rotavirus. Fourthly, after one hour's incubation at 
37°C and washing, alkaline-phosphatase-labeled anti-guinea-pig 
immunoglobulin is added. This mixture
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will react with any guinea-pig serum bound in the previous step. 
Fifthly, after a final wash to remove unbound enzyme, a substrate 
solution is added. Enzyme bound in the above step will react with 
the substrate to produce a visible color, which is measured in a 
spectrophotometer capable of determining optical density at a spe-
cific wavelength through the bottom of a microtiter plate." The en-
tire test is read when a weakly positive control specimen has 
reached a specified optical-density value. Determinations were ex-
pressed in terms of a positive over negative ratio,with the negative 
being the mean value of four human stools not containing 
rotavirus.
Initially, the type-specific human rotavirus guinea-pig antiserums 
were titered against bovine rotavirus (NCDV) by enzyme-linked 
immunosorbent assay. In subsequent experiments 8 antibody units 
as measured against NCDV were used to standardize rotavirus 
group reactivity. To establish variability of the type-specifc assay, 
three reference strains of human rotavirus Type 1 and three of Type 
2 were tested in quadruplicate with their homologous guinea-pig 
antiserum on five successive days. These experiments revealed a 
test-to-test standard deviation of the positive/negative values of 
approximately 8 per cent. Thus, in the serotyping procedure that 
used the Type 1 and Type 2 antiserums, a posi-tive/negative value 
that was 3 standard deviations or 24 per cent greater with one of 
the serum specimens than the other was considered to be 
indicative of that serotype. Most of the differences observed in 
positive/negative values between the type-specific serums were 
considerably greater than 24 per cent.
The enzyme-linked immunosorbent assay for measurement of 
serotype-specific antibody is outlined as follows: type-specific 
guinea-pig anti-human rotavirus serum, prepared as described 
above, is adhered to the well of a microtiter plate; after washing, 
homotypic rotavirus antigen — in the form of a stool suspension 
from a germ-free calf infected with human rotavirus, as previously 
described' — is added, and in addition, a stool suspension from a 
germ-free calf not infected with rotavirus is added to other wells as 
a control; after washing, the cross-reacting common rotaviral deter-
minants'10 are blocked by the addition of a calf serum that contains 
antibody to bovine rotavirus (this serum was obtained from a germ-
free calf after infection with NCDV), and the plates are stored in 
this way at 4°C until use; and, after another washing, dilutions of 
the serum or milk are added to wells containing Type 1, Type 2 and 
control antigen. The plates are then processed for anti-rotaviral IgG 
or IgA as previously described, with use of specific enzyme-labeled 
anti-human IgG and anti-human IgA.' The preparation and prop-
erties of the anti-human IgG conjugate have previously been de-
scribed.' The anti-human IgA conjugate was prepared in a similar 
way from goat antiserum to human IgA. This antiserum was made 
alpha-chain specific by affinity chromatography isolation of the an-
tibody. (This serum was obtained from Antibodies, Incorporated, 
Davis, California.)
A panel of 10 serum specimens was tested for type-specific rota-viral 
antibody of the IgG class, and 10 colostrums were tested for antibody 
of the IgA subclass. On five successive days, the mean of the standard 
deviations of the optical-density readings was 0.06 for the serums and 
0.08 for the colostrums. Assay of antibody and measurement of 
serologic response were performed by the end-point titration method. 
Each specimen was tested with three stool filtrates: one was a control 
filtrate derived from a gnotobiotic calf inoculated with the Norwalk 
virus, and the other two were derived from calves experimentally 
infected with Type 1 or Type 2 human rotavirus. A dilution of serum, 
milk or colostrum was considered to be positive if it yielded an 
optical-density value with Type 1 or Type 2 antigen that was 3 
standard deviations above that observed in the well containing the 
control stool filtrate. Specimens tested for antibody activity were 
diluted in twofold steps starting at 1:10 (human milk or colostrum) or 
1:50 (human serum).
For the antibody prevalence survey serums were tested at a single 
dilution of 1:100 against both test and control antigens as above. As 
previously described, a positive/negative value of greater than 2.0 at 
this dilution was considered indicative of the presence of rotavirus 
antibody to the type tested; the mean absorbance of five rotavirus 
antibody-negative serum specimens was used for the N value.' 
Statistical analyses were performed by the chi-square, Fisher's exact 
test or Student's two-tailed t-test where appropriate.
RESULTS
Initially a set of reference viruses (previously sero-
typed with guinea-pig antiserums by complement fix-
ation and immune electron microscopy) were assayed 
for type-specific antigen by the enzyme-linked immu-
nosorbent assay.' The three Type 1 strains had a mean 
positive/negative value of 5.6 when tested with 
guinea-pig anti-rotavirus Type 1 serum and a value of 
2.2 when tested with guinea-pig anti-rotavirus Type 2 
serum (P<0.01). Similarly, three Type 2 strains had a 
positive/negative value of 6.6 when tested with 
guinea-pig anti-rotavirus Type 2 serum and a value of 
2.4 when tested with the Type 1 serum (P<0.01). 
Thus, these serotypes were easily differentiated by 
this method. Rotavirus derived from animal species 
gave an equal reaction with Type 1 and Type 2 anti-
serums and thus could be distinguished from the 
human serotypes.
Distribution of Serotypes
A total of 278 rotaviruses obtained over a five-year 
period from pediatric patients with gastroenteritis liv-
ing in the Washington, D.C., area was serotyped by 
enzyme-linked immunosorbent assay (Table 1). 
Overall, 25 per cent of the patients shed rotavirus Type 
1, and 75 per cent Type 2. Nontypable rotavi-ruses 
were not encountered. There was a marked fluctuation 
in the temporal distribution of rotaviral sero-types. 
Thus, whereas Type I strains accounted for 14 per cent 
of the total from October, 1974, to September, 1976, 
this serotype made up 30 per cent of the total in the 
1976-1977 season, and 43 per cent in the 1977-78 
season. In addition, an examination of shorter periods 
within some of these seasons revealed clustering of 
cases of one serotype or the other. For ex-
ample, there were 20 illnesses associated with rotavi-
rus infection during February, 1978, 10 of which oc-
curred during the first half of the month, and all were 
identified as Type 2 virus. On the other hand, of the 10 
rotavirus illnesses sampled during the second half of 
the month, seven were Type 1. The proportion of Type 
1 and Type 2 infections among outpatients and 
inpatients with gastroenteritis was similar. There was 
no difference in the mean age of patients infected with 
the two serotypes.
An examination of specimens obtained from other areas 
of the world also indicated a variability in the
 
predominance of serotypes (Table 1). However, the 
overaIl frequency of Type 1 and Type 2 (18 per cent and 
82 per cent respectively) did not differ from that 
observed in the Washington, D.C., study (P>0.1).
V i r u l e n c e
The relative virulence of the two serotypes could not 
be determined from the Washington, D.C., study 
because of its cross-sectional nature. However, in the 
Guatemalan-cohort study, routine specimens were 
obtained on a biweekly basis as well as during epi-
sodes of gastroenteritis. An analysis of these samples 
revealed that all 16 Type 2 strains were associated 
with diarrhea, whereas only six of the 11 Type 1 
strains were shed at the time of acute gastroenteritis (
P<0.05) (Table 2). Five of the Type 2 infections led 
to clinically detectable dehydration, whereas this con-
dition was not observed during Type 1 virus infec-
tion. This difference approached but did not achieve 
statistical significance. We also had the opportunity to 
determine the serotype of rotaviruses detected in 
stools from eight asymptomatically infected new-
borns. These infants were in the nursery at a time 
when pediatric patients were hospitalized with rota-
viral gastroenteritis in a nearby ward." Each of the 
eight rotaviruses from the nursery group and each ro-
tavirus from the patients with gastroenteritis was Type 
2. Thus, Type 2 was capable of causing asymptomatic 
infection in the normal newborn.
Sequential Infections
Sequential infections with human rotavirus were 
documented in nine infants and children — two from 
the United States and seven from the Guatemalan-
cohort study (Table 3). Eight of the nine children 
shed a different rotavirus serotype during each of 
their sequential infections. Type 1 virus caused the 
first infection in eight of the nine sequential 
episodes. One child had two sequential Type 1 
infections within a 15-month interval, and both were 
asymptomatic. Another had three separate rotavirus 
infections; the first two, which were symptomatic, 
were caused by Type 1 and Type 2 respectively, 
whereas the third, which was caused by Type 1, was 
not associated with symptoms.
Specificity of Serotype Immune Response
Paired serum specimens from the following groups 
were examined for type-specific human rotaviral an-
tibody: six children with Type 1 infection, 12 children 
with Type 2 infection, six adult contacts of children 
with Type 1 infection, eight adult contacts of children 
with Type 2 infection and 10 adult volunteers ex-
perimentally infected with Type 2 human rotavirus.
t.
Although there was some cross-reactivity, the rise in 
homotypic antibody was greater than the heterotypic 
response, and most subjects had a fourfold increase in titer 
only to the infecting serotype.
Specificity of immune response was also examined by 
study of three discrete outbreaks of rotaviral gas-
troenteritis by type-specific enzyme-linked immuno-
sorbent assay (Table 4). Outbreak (A) consisted of 
nine children and 12 adult contacts ill with 
gastroenteritis. Eight stool specimens and four paired 
serum specimens were available from the children, 
and three stools and three paired serum specimens, 
from the adult contacts. A total of 10 of the 11 
patients from whom specimens were available shed 
Type 2 virus or showed a Type 2 seroresponse 
whereas none of these patients had evidence of Type 1 
infection. In outbreak (B), which involved an infant 
and both parents, each patient had symptoms of 
gastroenteritis, and a sero-response to Type 1 
rotavirus developed. Diarrheal stool samples were 
available from the mother and the infant, both of 
whom were found to shed Type 1 rotavirus. Similarly, 
in outbreak (C), which occurred on a naval vessel, 
only serologic evidence of Type 1 infection was 
observed in the three affected persons tested. 
Unfortunately, stool specimens were not available in 
this outbreak.
Acquisition of Antibody
Analysis of the prevalence of antibody to human ro-
tavirus Types 1 and 2 in 422 subjects six months to 60 
years of age indicated that infection with both Type 1 
and Type 2 viruses occurred at an early age; thus by 18 
months of age 85 per cent had antibody to each 
serotype (Fig_ 1). A difference in prevalence of anti-
body to Type 1 and Type 2 was not statistically sig-
nificant for any age group. In addition, there was no 
year-to-year variation in prevalence of antibody to 
either serotype among children six months to three 
years of age tested over the period 1974 through 1977.
Colostral and Milk Antibody
IgA antibody to the Type 1 and Type 2 rotaviruses 
was examined in 43 colostral and 64 milk specimens 
from women living in Bangladesh, Guatemala, Costa 
Rica and Washington, D.C. (Table 5). Eighty-eight 
per cent of the colostral specimens had IgA antibody 
to Type I rotavirus, and 91 per cent to Type 2. 
Although the geometric mean titer to each serotype 
was lower in milk than in colostrum (P<0.05), 88 per 
cent of the milks had antibody to Type I, and 88 per 
cent to Type 2. Only two specimens (both milk) 
lacked detectable antibody to both serotypes. The 
difference in geometric mean antibody titer to Type 
1 and Type 2 was not statistically significant for 
colostrum or milk.
The ability of a nursing mother to respond to infection 
with an antibody rise to a specific rotaviral type was 
documented in the case of a mother and child who 
were infected with rotavirus at about the same time. 
The rotavirus in the child's stool was identified as Type 
1. The mother's stool, which was positive for rotavirus 
by electron microscopy, was not available for 
serotyping. The mother had no detectable milk IgA 
antibody to Type 1 before infection but had a titer of 1:
320 37 days after infection. Her preinfection milk 
IgA antibody titer to rotavirus Type 2 was 1:80, and 
this titer did not change after infection.
DIscussion
The enzyme-linked immunosorbent assay was able to 
identify the serotype of rotaviruses derived from 
children living in a variety of locales. These findings 
confirm those of Zissis and Lambert, who described 
two rotaviral serotypes with the technics of comple-
ment fixation and immune electron microscopy.' The 
distinctness of these serotypes is clear from the tem-
poral variation in pattern of serotypes, the serotype-
specific immune response to infection and the homo-
geneity of the three outbreaks studied. Additional
convincing evidence for immunologic distinctness of 
the rotaviral serotypes emerged from the study of se-
quential illnesses caused by rotavirus. In each case the 
first illness was associated with Type 1, and the sec-
ond illness with Type 2. This observation suggests 
that infection with Type 1 does not induce note-
worthy resistance to Type 2. In the two cases in which 
a patient was reinfected with the same serotype the 
second infection was asymptomatic. Our observations 
confirm those of Fonteyne et al., who also found that 
sequential infections were caused by different 
serotypes.16,22
With the enzyme-linked immunosorbent assay, each 
of the 414 rotavirus strains tested could be classified 
as Type 1 or Type 2. Since the identification of 
serotype was defined as a greater reactivity with one 
reference serum than with the other, it is possible that 
minor serotypic variations exist that were not detect-
ed by this system. Similarly, additional serotypes, as 
have been reported,6 might not be detected by our 
technic if they were more closely related to one estab-
lished serotype than to the other. Further studies on 
sequential infections will be necessary to determine 
the number of serotypes that are important in human 
infection.
Although only 25 per cent of the isolates from 
symptomatic children from the Washington area over 
a five-year period were Type 1, seroepidemiologic 
analysis revealed that 85 per cent of children had de-
tectable antibody to both serotypes early in life, sug-
gesting that the clinical expression of Type 2 virus in-
fection is more pronounced than that of Type 1 virus. 
Observations made during the cohort study of 
Guatemalan children support this suggestion. Infec-
tion with Type 1 was asymptomatic in 45 per cent of 
cases, whereas every Type 2 infection was associated 
with gastroenteritis. This postulated greater virulence 
of type of human rotavirus is similar to that previous-
ly observed for Type 1 poliovirus, which exceeds the 
Type 2 and Type 3 polioviruses in neuropathogen-
icity 7
One of the fascinating and currently unexplained 
aspects of rotavirus epidemiology is the frequent oc-
currence of asymptomatic infection during the new- 
born period." ,19 Our analysis of eight such strains 
from England indicates that each was Type 2 — the 
same type that was associated with gastroenteritis 
that led to admission of older children to the same 
bospital. It is unclear why this serotype failed to in-
ice illness in the newborn whereas it exhibited 
rulence for older infants.
It has been noted in several studies that breast 
eding decreases the incidence of gastroenteritis in 
children.20 A previous study using the enzyme-
linked immunosorbent assay demonstrated presence 
of rota-ral antibodies in human colostrum and milk.
15 Ob-rvations made during the present study 
indicate at many samples of milk and colostrum 
contain Stibody directed against both serotypes. In 
addi-tion, the study of sequential milk specimens 
from a mother infected with Type 1 rotavirus revealed that 
she acquired a type-specific IgA antibody response. It 
is of interest that her child was infected with the rota-
virus serotype to which she did not have milk anti-
body at the time of infection. The role of breast-milk 
antibody in protection against rotaviral disease and 
the possibility of augmenting this antibody remain to 
be determined.
Infantile gastroenteritis is a major cause of morbidity 
in developed countries and a major cause of mortality 
in many developing countries of the world. 
Furthermore, infection with human rotavirus appears 
to be responsible for a substantial portion of gastro-
enteritis occurring in children six months to two years 
of age.4 One approach to prevention of this disease in 
piglets involves the use of a vaccine during infancy to 
induce active immunity and possibly also during late 
pregnancy to boost colostral and milk antibodies and 
thus to provide passive immunity to the nursing in-
fant.21 The realization that there are two distinct 
human rotaviruses that do not appear to provide 
noteworthy heterotypic immunity suggests that, to be 
completely effective, a vaccine must induce resistance 
to both serotypes.
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